| Literature DB >> 33674611 |
Jeremie Lemarié1, Ivana Zlatanova1, Icia Santos-Zas1, Marine Cachanado2, Jean-Christophe Seghezzi3, Hakim Benamer4, Pascal Goube5, Marie Vandestienne1, Raphael Cohen1, Maya Ezzo1, Vincent Duval1, Yujiao Zhang1, Jin-Bo Su6, Alain Bizé6, Lucien Sambin6, Philippe Bonnin7, Maxime Branchereau8, Christophe Heymes8, Corinne Tanchot1, José Vilar1, Clement Delacroix1, Jean-Sebastien Hulot1, Clement Cochain9, Patrick Bruneval1,10, Nicolas Danchin11, Alain Tedgui1, Ziad Mallat1,12, Tabassome Simon2,13, Bijan Ghaleh6, Jean-Sébastien Silvestre1, Hafid Ait-Oufella14,15.
Abstract
Acute myocardial infarction is a common condition responsible for heart failure and sudden death. Here, we show that following acute myocardial infarction in mice, CD8+ T lymphocytes are recruited and activated in the ischemic heart tissue and release Granzyme B, leading to cardiomyocyte apoptosis, adverse ventricular remodeling and deterioration of myocardial function. Depletion of CD8+ T lymphocytes decreases apoptosis within the ischemic myocardium, hampers inflammatory response, limits myocardial injury and improves heart function. These effects are recapitulated in mice with Granzyme B-deficient CD8+ T cells. The protective effect of CD8 depletion on heart function is confirmed by using a model of ischemia/reperfusion in pigs. Finally, we reveal that elevated circulating levels of GRANZYME B in patients with acute myocardial infarction predict increased risk of death at 1-year follow-up. Our work unravels a deleterious role of CD8+ T lymphocytes following acute ischemia, and suggests potential therapeutic strategies targeting pathogenic CD8+ T lymphocytes in the setting of acute myocardial infarction.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33674611 PMCID: PMC7935973 DOI: 10.1038/s41467-021-21737-9
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919